mevalonic acid and Atherogenesis

mevalonic acid has been researched along with Atherogenesis in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (37.50)29.6817
2010's9 (56.25)24.3611
2020's1 (6.25)2.80

Authors

AuthorsStudies
Agrawal, A; Ahmad, M; Ahmad, T; Ghosh, B; Khanna, K; Kulshreshtha, A; Singh, S1
Billington, EO; Reid, IR1
Casal-Dominguez, M; Mammen, AL; Pinal-Fernandez, I1
Ohukainen, P1
Benchitrit, J; Drüeke, TB; Edelman, A; Galmiche, A; Guerrera, IC; Guillonneau, F; Ivanovski, O; Joki, N; Lacour, B; Lucas, A; Maizel, J; Marçon, F; Massy, ZA; Nguyen-Khoa, T; Nikolov, IG; Phan, O1
Chen, GP; Du, CQ; Han, J; Li, L; Wu, T; Zhang, XQ1
Emmott, A; Leask, RL; Rossi, J; Rouleau, L; Tardif, JC1
Ishibashi, T1
Cheng, KM; Godin, DV; Li, X; Schulte, P1
Keizer, HG1
Barbagallo, M; Bevilacqua, M; Dominguez, LJ; Rosini, S1
Blanco-Colio, LM; Egido, J; Gómez-Hernández, A; Hernández, G; Martín-Ventura, JL; Ortega, L; Ortego, M; Sánchez-Galán, E; Serrano, J; Tunón, J; Vega, M; Vidal, C1
Cai, YC; Fang, Y; Li, JQ; Li, P; Li, QZ; Wu, LR; Zhao, SP1
Hu, WL; Li, JJ; Qian, SB; Qiao, SB1
Inaba, M; Nishizawa, Y; Yamada, S1
Aparicio, C; Blanco-Colio, LM; Egido, J; Esbrit, P; Martin-Ventura, JL; Ortega, L1

Reviews

5 review(s) available for mevalonic acid and Atherogenesis

ArticleYear
Benefits of Bisphosphonate Therapy: Beyond the Skeleton.
    Current osteoporosis reports, 2020, Volume: 18, Issue:5

    Topics: Atherosclerosis; Bone Density Conservation Agents; Breast Neoplasms; Colorectal Neoplasms; Diphosphonates; Disease Progression; Endothelial Cells; Humans; Macrophages; Mevalonic Acid; Monocytes; Mortality; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Protective Factors; Vascular Calcification

2020
Statins: pros and cons.
    Medicina clinica, 2018, 05-23, Volume: 150, Issue:10

    Topics: Anti-Inflammatory Agents; Anticholesteremic Agents; Atherosclerosis; Blood Coagulation; Cardiovascular Diseases; Cerebral Hemorrhage; Cholesterol; Diabetes Mellitus, Type 2; Endothelium, Vascular; Fibrinolytic Agents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunologic Factors; Inflammation; Mevalonic Acid; Musculoskeletal Diseases

2018
[Anti-atherosclerotic and anti-inflammatory effects of statin on cardiovascular disease and their mechanisms].
    Nihon rinsho. Japanese journal of clinical medicine, 2011, Volume: 69, Issue:1

    Topics: Animals; Atherosclerosis; Cardiovascular Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Mevalonic Acid; Monomeric GTP-Binding Proteins; Plaque, Atherosclerotic; Pravastatin; Primary Prevention; Randomized Controlled Trials as Topic; Secondary Prevention

2011
Bisphosphonates and atherosclerosis: why?
    Lupus, 2005, Volume: 14, Issue:9

    Topics: Apoptosis; Atherosclerosis; Bone Resorption; Calcinosis; Cholesterol; Diphosphonates; Humans; Macrophages; Mevalonic Acid; Molecular Structure

2005
[Influence on atherosclerosis of improvement of bone mineral density after medication for osteoporosis].
    Nihon rinsho. Japanese journal of clinical medicine, 2007, Nov-28, Volume: 65 Suppl 9

    Topics: Alendronate; Apolipoprotein A-I; Arthritis, Rheumatoid; Atherosclerosis; Bone and Bones; Bone Density; Bone Density Conservation Agents; Cholesterol, HDL; Humans; Mevalonic Acid; Osteoporosis

2007

Other Studies

11 other study(ies) available for mevalonic acid and Atherogenesis

ArticleYear
Simvastatin mediates inhibition of exosome synthesis, localization and secretion via multicomponent interventions.
    Scientific reports, 2019, 11-08, Volume: 9, Issue:1

    Topics: Animals; Asthma; Atherosclerosis; Cell Line; Cholesterol; Disease Models, Animal; Exosomes; Human Umbilical Vein Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Mevalonic Acid; Mice; Mice, Inbred BALB C; Monocytes; Simvastatin

2019
If the wheel ain't broke, don't reinvent it.
    Lipids in health and disease, 2013, Apr-11, Volume: 12

    Topics: Atherosclerosis; Cholesterol; Humans; Mevalonic Acid; Models, Cardiovascular

2013
Farnesyltransferase inhibitor R115777 protects against vascular disease in uremic mice.
    Atherosclerosis, 2013, Volume: 229, Issue:1

    Topics: Animals; Aorta; Apolipoproteins E; Apoptosis; Atherosclerosis; Blood Proteins; Body Weight; Collagen Type I; Enzyme Inhibitors; Farnesyltranstransferase; Female; Kidney Failure, Chronic; Liver; Macrophages; Mevalonic Acid; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Prenylation; Quinolones; Random Allocation; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tyrosine; Uremia; Vascular Calcification

2013
Alteration of mevalonate pathway in proliferated vascular smooth muscle from diabetic mice: possible role in high-glucose-induced atherogenic process.
    Journal of diabetes research, 2015, Volume: 2015

    Topics: Acyl Coenzyme A; Alkyl and Aryl Transferases; Animals; Aorta; Atherosclerosis; Blood Glucose; Cell Proliferation; Diabetes Mellitus, Experimental; Farnesyltranstransferase; Female; Geranylgeranyl-Diphosphate Geranylgeranyltransferase; Geranyltranstransferase; Glucose; Inflammation; Lipids; Mevalonic Acid; Mice; Mice, Inbred BALB C; Muscle, Smooth, Vascular

2015
Laminar shear stress prevents simvastatin-induced adhesion molecule expression in cytokine activated endothelial cells.
    European journal of pharmacology, 2010, Dec-15, Volume: 649, Issue:1-3

    Topics: Anticholesteremic Agents; Aorta, Abdominal; Atherosclerosis; Blotting, Western; Cell Adhesion Molecules; Cell Line; Cytokines; Endothelium, Vascular; Gene Expression Regulation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intercellular Adhesion Molecule-1; Mevalonic Acid; Osmolar Concentration; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Simvastatin; Stress, Mechanical; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1

2010
Differential mRNA expression of seven genes involved in cholesterol metabolism and transport in the liver of atherosclerosis-susceptible and -resistant Japanese quail strains.
    Genetics, selection, evolution : GSE, 2012, Jun-08, Volume: 44

    Topics: Animals; Atherosclerosis; Biological Transport; Cholesterol; Coturnix; Diet; Disease Resistance; Disease Susceptibility; Gene Expression Profiling; Gene Expression Regulation; Lipoproteins, HDL; Lipoproteins, LDL; Liver; Male; Mevalonic Acid; Real-Time Polymerase Chain Reaction; Regression Analysis; RNA, Messenger; Signal Transduction; Triglycerides

2012
The "Mevalonate hypothesis": a cholesterol-independent alternative for the etiology of atherosclerosis.
    Lipids in health and disease, 2012, Nov-05, Volume: 11

    Topics: Atherosclerosis; Biomarkers; Cardiovascular Diseases; Cholesterol; Free Radicals; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Metabolic Networks and Pathways; Mevalonic Acid; Models, Cardiovascular

2012
Atorvastatin reduces the expression of prostaglandin E2 receptors in human carotid atherosclerotic plaques and monocytic cells: potential implications for plaque stabilization.
    Journal of cardiovascular pharmacology, 2006, Volume: 47, Issue:1

    Topics: Aged; Atherosclerosis; Atorvastatin; Carotid Artery Diseases; Cells, Cultured; Cyclooxygenase 2; Dinoprostone; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracellular Signaling Peptides and Proteins; Intramolecular Oxidoreductases; Male; Matrix Metalloproteinase 1; Mevalonic Acid; Middle Aged; Monocytes; Prostaglandin-E Synthases; Protein Serine-Threonine Kinases; Pyrroles; Receptors, Prostaglandin E; rho GTP-Binding Proteins; rho-Associated Kinases

2006
Atorvastatin reduces plasminogen activator inhibitor-1 expression in adipose tissue of atherosclerotic rabbits.
    Clinica chimica acta; international journal of clinical chemistry, 2006, Volume: 370, Issue:1-2

    Topics: Adipose Tissue; Animal Feed; Animals; Atherosclerosis; Atorvastatin; Cholesterol; Gene Expression Regulation; Heptanoic Acids; Male; Mevalonic Acid; Plasminogen Activator Inhibitor 1; Pyrroles; Rabbits; RNA, Messenger; Triglycerides

2006
Decreased C-reactive protein-induced resistin production in human monocytes by simvastatin.
    Cytokine, 2007, Volume: 40, Issue:3

    Topics: Animals; Atherosclerosis; C-Reactive Protein; Cells, Cultured; Coronary Disease; Diterpenes; Dose-Response Relationship, Drug; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin Resistance; Mevalonic Acid; Monocytes; Polyisoprenyl Phosphates; Resistin; Risk Factors; Rodentia; Signal Transduction; Simvastatin; Time Factors; Up-Regulation

2007
LDL induces parathyroid hormone-related protein expression in vascular smooth muscle cells: Modulation by simvastatin.
    Atherosclerosis, 2008, Volume: 198, Issue:2

    Topics: Animals; Atherosclerosis; Cells, Cultured; Disease Models, Animal; Femoral Artery; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Macrophages; Male; Mevalonic Acid; Muscle Cells; Muscle, Smooth, Vascular; Parathyroid Hormone-Related Protein; Polyisoprenyl Phosphates; Rabbits; Receptor, Parathyroid Hormone, Type 1; RNA, Small Interfering; Simvastatin; Tunica Intima; Up-Regulation

2008